Shuo Shen,1*,
Xiaoming Yang,2
Choong-Tat Keng,1
Aihua Zhang,2
Hsueh-Ling Janice Oh,1
Zhi-Hong Li,1
Le-Ann Hwang,1
Chih-Fong Chou,1
Burtram C. Fielding,1
Timothy H. P. Tan,1
Josef Mayrhofer,3
Falko G. Falkner,3
Jianlin Fu,1
Seng Gee Lim,1
Wanjin Hong,1 and
Yee-Joo Tan1
Institute of Molecular and Cell Biology, Singapore 138673,1 Wuhan Institute of Biological Products, Wuhan, P. R. China 430060,2 Baxter Vaccines, Orth/Donau, Austria3
Received 7 June 2005/ Accepted 19 October 2005
We have previously shown that an Escherichia coli-expressed, denatured spike (S) protein fragment of the severe acute respiratory coronavirus, containing residues 1029 to 1192 which include the heptad repeat 2 (HR2) domain, was able to induce neutralizing polyclonal antibodies (C. T. Keng, A. Zhang, S. Shen, K. M. Lip, B. C. Fielding, T. H. Tan, C. F. Chou, C. B. Loh, S. Wang, J. Fu, X. Yang, S. G. Lim, W. Hong, and Y. J. Tan, J. Virol. 79:3289-3296, 2005). In this study, monoclonal antibodies (MAbs) were raised against this fragment to identify the linear neutralizing epitopes in the functional domain and to investigate the mechanisms involved in neutralization. Eighteen hybridomas secreting the S protein-specific MAbs were obtained. Binding sites of these MAbs were mapped to four linear epitopes. Two of them were located within the HR2 region and two immediately upstream of the HR2 domain. MAbs targeting these epitopes showed in vitro neutralizing activities and were able to inhibit cell-cell membrane fusion. These results provide evidence of novel neutralizing epitopes that are located in the HR2 domain and the spacer region immediately upstream of the HR2 of the S protein.
K.-M.L. and S.S. contributed equally to this article.
This article has been cited by other articles:
| J. Bacteriol. | Mol. Cell. Biol. | Microbiol. Mol. Biol. Rev. |
|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|